Dr Vickers is the President and CEO of Northern Biologics. He has more than two decades’ experience in the biotech and pharmaceutical industry, having held leaderships positions in Research & Development at Shire, Merck, Pfizer, Boehringer-Ingelheim and Resolvyx Pharmaceuticals. He is a member of the board of Revance Therapeutics.
Dr Vickers holds a PhD in Biochemistry from the University of Toronto and a BSc in Applied Biochemistry from the University of Salford, United Kingdom. He was a Visiting Fellow at the National Cancer Institute in Bethesda, Maryland, prior to entering the pharmaceutical industry.